Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41
Published April 16, 2025 · Recall initiated: March 21, 2025
Summary
FDA records drug Class II recall D-0356-2025, published April 16, 2025 and initiated March 21, 2025. Recalling firm: Somerset Therapeutics Private Limited; Status: Ongoing; Reported quantity: 4956 vials; Lot: A240467B, exp. date 07/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Media fill with bacterial contamination
What to do
Voluntary: Firm initiated · Letter
Get an email if HALOPERIDOL DECANOATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HALOPERIDOL DECANOATE
- Manufacturer
- Somerset Therapeutics Private Limited
- Distributor
- U.S. Nationwide
- UPC
- 0368001578592
- Lot
- A240467B, exp. date 07/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAHaloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: SomersetApril 30, 2025
- FDAHaloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: SomersetApril 30, 2025
- FDAHaloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by SomersetApril 30, 2025
- FDAHaloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: SomersetApril 16, 2025
- FDAHaloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: SomersetApril 16, 2025
- FDAHaloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: SomersetApril 16, 2025
Questions about this recall
Was Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41 recalled?
Yes. FDA published recall D-0356-2025 on April 16, 2025. Reported hazard: Lack of Assurance of Sterility: Media fill with bacterial contamination
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HALOPERIDOL DECANOATE. UPC: 0368001578592.